Effect of magnesium sulphate infusion on neonatal outcomes in babies with perinatal asphyxia
A randomized controlled trial
Keywords:
neonates, magnesium, seizures, RCTAbstract
Introduction- With a relatively scant evidence base in Indian population, this study aimed to determine the efficacy of intravenous magnesium sulphate in neonates with moderate to severe perinatal asphyxia on the severity of seizures, number of anticonvulsants used, duration of hospitalization and feeding pattern at discharge. Methodology- This was a non-blinded randomized controlled trial that was conducted among 227 neonates admitted to the SNCU of MKCG Medical College Hospital. Randomization and allocation of eligible neonates was done using software. The intervention used was magnesium sulfate given intravenously by trained pediatricians in a loading dose of 250 mg/kg/dose, given over 1 hour in 20 ml of 5% dextrose solution. This was given at the time of admission followed by two infusions of the same dosage after 24 and 48 hours of the first dose. Outcomes on neonatal feeding, survival, need for medications and seizure management were recorded and analysed using an intention to treat protocol. Results- The distribution of most clinico-social parameters were comparable between the 2 groups. The babies who received MgSO4 within 6 hours of life achieved earlier initiation of feeds (32 hours) as compared to control groups (63 hrs). They also reached full feeding significantly earlier.
Downloads
References
World Health Organization. Perinatal mortality: a listing of available information [Internet]. Available from: FRH/MSM.96.7.Geneva:WHO,1996.
Dilenge ME, Majnemer A, Shevell MI. Long-term developmental outcome of asphyxiated term neonates. J Child Neurol. 2001;16:781–92.
Report of the National Neonatal Perinatal Database. India: National Neonatology Forum; 2003.
Cloherty and Stark’s manual of neonatal care. In: Chapter 55,Perinatal Asphyxia and Hypoxic -Ischemic Encephalopathy;p794. South Asian. Philadelphia: Wolters Kluwer; 2021. p. 800.
Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;5;375(9730):1969-87.
Lawn JE, Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, et al. Lancet’s Stillbirths Series steering committee. Stillbirths: Where?When? Why? How to make the data count? Lancet. 2011;23;377(9775):1448-63. Epub2011 Apr 13.
Volpe JJ. Neurology of the Newborn. Philadelphia: WB Saunders Co,1981,pp141-179;
Rouse DJ. Magnesium sulfate for the prevention of cerebralpalsy. AJOG 2009 (June);200(6):610.
Kuban KCK, Leviton A, M P. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child. 1992;7:70–6.
Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics. 1995;95(2):263–9.
Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 1996;276(22):1805–10.
Teng RJ, Wu TJ. Persistent pulmonary hypertension of the newborn. Journal of the Formosan Medical Association. 2013;1;112(4):177-84.
Andrews T, Banks J. The use of magnesium sulfate in acute asthma: Rapid uptake of evidence in North American emergency departments. Pediatrics2007;120;S146-S147;
Berger R, Garnier Y. Perinatal brain injury. J Perinat Med. 2000;28(4):261–85.
Gathwala G. Neuronal protection with magnesium. Indian J Pediatr. 2001;68(5):417–9.
Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984;307:462–5.
Enomoto T, Osugi T, Satoh H, McIntosh TK, Nabeshima T. Pre-Injury magnesium treatment prevents traumatic brain injury-induced hippocampal ERK activation, neuronal loss, and cognitive dysfunction in the radial-arm maze test. J Neurotrauma. 2005;22:783–92.
Ichiba H, Tamai H, Negishi H, Ueda T, Kim TJ, Sumida Y. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatr Int Off J Jpn Pediatr Soc. 2002;Oct;44(5):505–9.
Ichiba H, Yokoi T, Tamai H, Ueda T, Kim TJ, Yamano T. Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfate. Pediatr Int. 2006;48(1):70–5.
Pius S, Bello M, Ambe JP, Machoko Y, Clement AY, Genesis R. Pilot Study: Magnesium Sulphate Administration and Early Resolution of Hypoxic Ischemic Encephalopathy in Severe Perinatal Asphyxia. Open J Pediatr. 2019 Jan;11;9(1):89–102.
Bhat MA, Charoo BA, Bhat JI, Ahmad SM, Ali SW, M-U-H M. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics. 2009;May;123(5):e764-769.
Tagin M, Shah PS, Lee KS. Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis. J Perinatol. 2013;Sep;33(9:663–9.
Sample Size Calculator [Internet]. [cited 2022 May 22]. Available from: https://clincalc.com/stats/samplesize.aspx
randomize function - RDocumentation [Internet]. [cited 2022 May 21]. Available from: https://www.rdocumentation.org/packages/experiment/versions/1.2.1/topics/randomize
Siddiqui MA, Butt TK. Role of Intravenous Magnesium Sulphate in Term Neonates with Hypoxic Ischemic Encephalopathy (HIE) in a Low-income Country: A Randomised Clinical Trial. J Coll Physicians Surg–Pak JCPSP. 2021 Jul 30;
Savitha M, Rajprakash R. Beneficial effect of intravenous magnesium sulphate in term neonates with perinatal asphyxia. Int J Contemp Pediatr. 2016 Jan 1;
Farargy MS, Soliman NA. A randomized controlled trial on the use of magnesium sulfate and melatonin in neonatal hypoxic ischemic encephalopathy. J Neonatal-Perinat Med. 2019;12(4):379–84.
Gathwala G, Khera A, Singh J, Balhara B. Magnesium for neuroprotection in birth asphyxia. J Pediatr Neurosci. 2010;Jul;5(2):102–4.
Levene M, Blennow M, Whitelaw A, Hanko E, Fellman V, Hartley R. Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child Fetal Neonatal Ed. 1995;73(3):174–7.
Iqbal N, Younus J, Malik M, Fatima B, Imran A, Maqbool S. The Neuroprotective Efficacy of Postnatal Magnesium Sulfate in Term or Near-Term Infants With Moderate-to-Severe Birth Asphyxia. Cureus. 2021;Aug;13(8):e16826. 30.
Anabrees J. Magnesium sulphate for newborns with HIE; synopsis of evidence from a systematic review. J Clin Neonatol. 2013;Jul;2(3):114–6.
Okonkwo IR, Okolo AA. Postnatal Magnesium Sulfate in Asphyxiated Newborns in Benin City Nigeria: Effect on Mortality.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
